Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Oncotarget|December 13, 2017
Lenalidomide overcomes the immunosuppression of regulatory CD8<sup>+</sup>CD28<sup>-</sup> T-cellsBrigitte Neuber, Jingying Dai, Wjahat A Waraich, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2015
Bone Marrow Harvesting of Allogeneic Donors in an Outpatient Setting: A Single-Center ExperienceKatharina Lisenko, Peter Stadtherr, Thomas Bruckner, et al.
Experimental Hematology|November 13, 2012
Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myelomaIsabelle Herth, Mathias Witzens-Harig, Philipp Beckhove, et al.
Oncoimmunology|September 14, 2016
The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cellsSonja Textor, Felicitas Bossler, Kai-Oliver Henrich, et al.
Transfusion|August 14, 2014
Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myelomaJian Cheng, Michael Schmitt, Patrick Wuchter, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2009
Oncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: In vitro and in vivo studiesAssia L Angelova, Marc Aprahamian, Ginette Balboni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Impact of rituximab and radiotherapy on outcome of patients with aggressive B-cell lymphoma and skeletal involvementGerhard Held, Samira Zeynalova, Niels Murawski, et al.
Blood|June 19, 2014
The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomasNiels Murawski, Gerhard Held, Marita Ziepert, et al.
Annals of Hematology|April 22, 2020
Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphomaAndrew Davies, Peter Trask, Judit Demeter, et al.
European Journal of Haematology|March 28, 2008
Identification of HLA-A2 restricted T-cell epitopes within the conserved region of the immunoglobulin G heavy-chain in patients with multiple myelomaSebastian Belle, Fang Han, Maud Condomines, et al.
Pageof 8